Category Archives: Market Research

3D Cell Culture Market to Expand with Significant CAGR During 2017 – 2025

3D cell culture is a controlled simulated environment outside of a living organism, wherein cells are allowed to grow and migrate by interacting within their habitat. 3D cell culture nurtures levels of cell differentiation and tissue organization which is not viable in traditional 2D culture systems. 3D cell culture has more tissue divergence and cell cohesion properties. 3D cell structures are gaining popularity and have shown increased applications, especially in the early drug discovery and other research and development. This technique is used by researchers to fabricate physiologically similar cell culture stereotypes that aid drug discovery and development. Persistent need to refine efficiency in pharmaceutical research and development is also encouraging the use of 3D cell cultures.

Read Report Overview: https://www.transparencymarketresearch.com/3d-cell-culture-market.html

3D cell culture is one of the rapidly growing segments in the health care space due to considerable range of applications in cancer research, in vitro environment, and regenerative medicine. The ability of 3D cell culture to strengthen the understanding of tissue maturation and organization, organogenesis, and cell differentiation has increased its utility. It has also replaced animal prototypes in clinical testing and experiments, as these look similar to cells in vivo. Increase in adoption of 3D cell culture in diagnostic centers, hospitals, and pharmaceutical and biotech companies, and rise in demand in organ transplantation, tissue regeneration, and regenerative medicine. The major drivers of the 3D cell culture market. Researchers are conducting experiments to advance and develop better options for culturing cells, and 3D cell culturing presents various benefits such as gaining better information and helping to conduct better research. 3D cell structures are relatively thicker. Hence, these could experience some potential barriers. Cells could react and emerge differently in 3D cell culture environment. This would require changes in experiments.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35834

The global 3D cell culture market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be divided into scaffold-based 3D cell culture (hydrogels /ECM analogs, micro patterned surfaces, and solid scaffolds), scaffold-free 3D cell culture (low adhesion micro plates, 3D petri dishes, 3D bioreactors, and hanging drop plates), microfluidics-based 3D cell culture, magnetic levitation, and 3D bio printing. Based on application, the global 3D cell culture market can be classified into drug discovery and toxicology, cancer and stem cell research, and tissue engineering & regenerative medicine. In terms of end-user, the market can be categorized into pharmaceutical & biotechnology companies and research laboratories and institutes.

Geographically, the global 3D cell culture market can be segmented into North America, Latin America, Europe, Asia Pacific, and Rest of the world. North America and Europe dominate the market. High market share of these regions is attributed to rise in prevalence of cancer and increase in investment in R&D and health care. Moreover, governments in these regions support advancement in the field of 3D cell culture through grants and funds. The market in Asia Pacific is expected to expand at a high CAGR due to increase in demand for 3D cell culture in developing nations.

Pre Book 3D Cell Culture Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=35834&ltype=S

Major players in the global 3D cell culture market are Merck, InSphero, Lonza, Thermo Fisher Scientific, Inc., ReproCELL, Inc., Nano3D Biosciences, Inc., Corning Technologies, Synthecon Incorporated, Global Cell Solutions, 3D Boitek, Kuraray Co. Ltd., Hamilton Company, Mimetas, and QGel.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Advertisements

Drug Discovery Informatics Market to Expand with Significant CAGR During 2017 – 2025

Drug discovery is a process that involves generating of a large volume of information and data. Several innovative technologies are used for this data generation. With the use of cloud-based technologies, it is now possible to process, store, and analyze a large volume of data at a low cost. The pathway analysis of drug discovery includes the identification of potential drug targets associated with diseases, applications in biomarker studies, and the study of protein interactions. Various biomarkers in drug discovery are included because biomarkers indicates a change in expression studies, this informatics helps in categorization of potential biomarkers. They are used to identify new targets; validate the new targets; identify the biomolecules in regulatory pathways; offer decisions for molecular designs; and explore new indications to existing new targets. In the next few years, shortage of information technology and aspects of the data evaluation can hamper the global demand.

Read Report Overview: https://www.transparencymarketresearch.com/drug-discovery-informatics-market.html

The global drug discovery informatics market has been segmented by product, mode, service, and geography. Based on product, the market can be segmented into discovery informatics and development informatics. The discovery informatics segment has been sub-divided into lead generation informatics, identification & validation informatics, and assay development informatics. The development informatics segment is further classified into lead optimization, phase IA informatics, phase IB/2 informatics, and FHD preparation. The discovery informatics segment accounts for the leading market share, owing to higher usage of information technology in the market and development of several software for drug discovery informatics. Based on mode, the global drug discovery informatics market has been divided into in-house informatics and outsourced informatics. The outsourced informatics segment holds a major share, as the number of contract research organizations (CROs) is growing. Based on service, the market has been segmented into sequence analysis platforms, molecular modeling, docking, clinical trial data management, and others. Various drugs are being developed and clinical trials are being conducted oncology, as various types of cancer are increasingly prevailing day by day.

Geographically, the global drug discovery informatics market has been segmented into five major regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of revenue, North America leads the global drug discovery informatics market. This is attributable to the advancement in technology for drug discovery informatics, increase in health care expenditure by governments, and availability of grants and funding from government organizations in the region. The market in Asia Pacific is expected to witness robust growth from 2017 to 2025, due to growing health care industry, economic development, and wide patient base in the region.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33713

In addition, there exist a number of factors positively affecting the drug discovery informatics market such as shift in preference of pharmaceutical companies toward the outsourcing of clinical and preclinical trials to focus on their core businesses. Moreover, the drug discovery informatics saves the time of companies and makes products available in the market in minimum time. The increase in the number of patients and different diseases across the globe has raised the number of pipeline products. This, in turn, drives the drug discovery informatics market. However, the market also faces certain restraints such as quality of the drug discovery, high cost of software, and not presence of suitable software for specific tests.

The major players operating in the global drug discovery informatics market are Infosys Limited, Certara, L.P., Boehringer Ingelheim GmbH, Charles River Laboratories International, Inc., DiscoverX Corporation, ChemAxon Ltd., Albany Molecular Research Inc., Selvita, Jubilant Life Sciences Ltd., GVK Biosciences Private Limited, Collaborative Drug Discovery, Inc., and Novo Informatics

Pre Book Drug Discovery Informatics Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=33713&ltype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Autologus Tissue Repair Market Estimated to Experience a Hike in Growth by 2024

Global Autologous Tissue Repair Market: Overview

The growing therapeutic applications of regenerative medicines has made a mark in the area of wound care such as those in refractory injuries and chronic wounds. With rapid advances in regenerative medicines, stem cells have gained increased popularity across autologous tissue engineering methods. Apart from wide applications in surgical medicine, the evolution of the market has influenced multiple clinical areas such as cardiovascular medicines, refractory wound care, and orthopedics. Prominent clinical applications of autologous tissue repair include bone repair, cardiac repair, neural repair, skeletal muscle repair, and pediatric vascular conduits.

Technological advances have led researchers and clinicians in isolating, purifying, and re-injecting patient’s cells in refractory injuries with significant reliability and efficacy. In recent years, autologous tissue repair methods have emerged to be highly promising in abdominal wall reconstruction associated with chronic infections. These are mainly caused by intra-abdominal catastrophes and due to several technical constraints are difficult to close.

Read Report Overview: https://www.transparencymarketresearch.com/autologus-tissue-repair-market.html

The report offers in-depth insights into the key drivers and restraints, notable trends and emerging applications, technological advancements, market share and size of various segments, and competitive landscapes. The insights offered in the study are useful in evaluating lucrative avenues across various regions.

Global Autologous Tissue Repair Market: Trends and Opportunities

The growing prevalence of intractable ailments in a rapidly increasing geriatric populations across various regions and the increasing number of road accidents are the key factors driving the analogous tissue repair market. In addition, the growing prominence of autologous tissue repair therapies in chronic wound care and orthopedics has boosted the autologous tissue repair market. The increasing adoption of components separation technique (CST) for autologous repair of abdominal wall defects is anticipated to catalyze the market growth.

A growing number of therapeutic autologous therapies can also be accessed using point-of-care setting, thereby accentuating the autologous tissue repair market. However, the high cost of availing autologous tissue repair therapies is likely to hinder the market to an extent. In addition, strict regulatory compliance for the approval of these therapies has impeded the growth of the market in various regions. Nevertheless, recent progress in stem cell-based tissue engineering has further expanded the autologous approaches to tissue engineering. For instance, recent research in intervertebral disc regeneration shows that stem cells can be used to treat slipped discs. Furthermore, the growing popularity of multipotent stem cells is expected to accentuate the autologous tissue repair market. Clinical studies on improving the efficacy of CST and other similar methods are expected to create exciting opportunities in the coming years.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4680

Global Autologous Tissue Repair Market: Regional Outlook

North America is a prominent market for the autologous tissue repair market. The substantial growth of this regional market is attributed to the large scale presence of several players in the region. Europe is another prominent regional market and the extensive demand for autologous tissue repair is propelled by a large chunk of elderly population.

Asia Pacific is expected to grow at an impressive pace. The impressive growth of the market is driven by advances in healthcare infrastructure, frequent innovative product launches, and the swift pace of industrialization rate in emerging countries in the region. A major chunk of the demand is expected to come from countries such as India, Japan, Malaysia, and China.

Global Autologous Tissue Repair Market: Companies mentioned in the report

Some of the prominent companies operating in the autologous tissue repair market are Vericel Corporation, Matricel GmbH, and Orthocell Limited. Several companies are launching innovative products and entering into partnerships to consolidate their shares across major regions.

Pre Book Autologous Tissue Repair Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=4680&ltype=S

 

Ophthalmic Lasers Market to Become Worth US$ 697.1 Mn by 2026

Future Market Insights provides a detailed analysis of the global ophthalmic lasers market in a new report titled “Ophthalmic Lasers Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. The global ophthalmic lasers market was valued at US$ 421.5 Mn in 2015 and is estimated to reach US$ 437.2 Mn by 2016 end, with a Y-o-Y growth rate of 3.7%.

Market dynamics

Factors such as rising prevalence of ophthalmic diseases leading to laser ophthalmic procedures and a growing elderly population susceptible to ophthalmic diseases such as cataract and glaucoma is anticipated to fuel the revenue growth of the global ophthalmic lasers market over the forecast period. Factors such as growing ophthalmic care expenditure, rising government provision in developed economies, constructive reimbursement policies, and increasing disposable income per capita are anticipated to enhance the growth of the global ophthalmic lasers market over the forecast period. However, high costs associated with ophthalmic lasers and replacement of current ophthalmic laser technology with advanced technologies might hinder the growth of the global ophthalmic lasers market over the forecast period.

View Report Preview: https://www.futuremarketinsights.com/reports/ophthalmic-lasers-therapeutic-market

Segmentation highlights

The global ophthalmic lasers market is segmented on the basis of Product Type (Photo-coagulation Lasers, Photo-disruption Lasers, Selective Laser Trabeculoplasty); Disease Type (Diabetic Retinopathy, Glaucoma Surgery, Cataract Surgery, Others); and End User (Hospitals, Ambulatory Surgical Centres, Ophthalmic Clinics).

  • The Selective Laser Trabeculoplasty product type segment is estimated to reflect a Y-o-Y growth rate of 4.3%. The Photo-coagulation Lasers segment is anticipated to register a CAGR of 4.6% over the forecast period.
  • The Glaucoma Surgery disease type segment is estimated to account for the highest market revenue share of the global ophthalmic lasers market by 2016 end. The Diabetic Retinopathy segment is estimated to account for the second highest market share of the global ophthalmic lasers market by 2016.
  • The Ophthalmic Clinics end user segment is anticipated to account for the highest market share of 45.1% of the global ophthalmic lasers market by 2016 end and register a CAGR of 5.6% over the forecast period. The Ambulatory Surgical Centres segment is estimated to reflect a Y-o-Y growth of 3.9% in 2016 over 2015.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Regional forecast

The global ophthalmic lasers market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. North America is expected to dominate the global ophthalmic lasers market in terms of revenue and is estimated to be valued at US$ 242.4 Mn by the end of 2026. North America is anticipated to account for the highest market share of 31.8% of the global ophthalmic lasers market by the end of 2016 while Western Europe is estimated to hold the second highest market share of 33.9% of the global ophthalmic lasers market by the end of 2016. The North America, Western Europe, and APEJ markets represent the highest growth opportunities in the global ophthalmic lasers market owing to a large patient population and more demand for laser technologies in diabetic retinopathy and glaucoma surgeries.

Vendor insights

The global ophthalmic lasers market report profiles some of the top companies operating in the global ophthalmic lasers market. Leading market players featured in the report are Ellex Medical PTY Ltd., Lumenis Ltd., IRIDEX Corporation, ZEISS International, NIDEK CO. LTD., Novartis AG, Topcon Corporation, and Quantel SA. These companies are focussing on developing new technologies to aid in seamless ophthalmic surgeries and are looking to penetrate new and emerging markets through strategic acquisitions.

 

PV Micro Inverters Market to Expand with Significant CAGR During 2017 – 2022

The global PV micro inverters market is characterized by the rivalry between the leading vendors of PV micro inverters across the world, such as Sungrow Power Supply Co. Ltd., ABB Ltd., General Electric, Enphase Energy Inc., SunPower Corp., and Darfon Electronics Corp., finds a new research study by Transparency Market Research (TMR). These companies are aggressively concentrating on technological advancements in their products to strengthen their presence in the overall market. Continual introduction of new and innovative products is also a key strategy adopted by these players for the development of their businesses.

Over the forthcoming years, the competition within the market is expected to intensify as a number of enterprises are shifting their focus towards emerging economies, having abundant untapped potential, notes the research study.

View Report Preview: https://www.transparencymarketresearch.com/pv-micro-inverters-market.html

Continued Dominance of North America

As per TMR’s estimation, the opportunity in the worldwide PV micro inverters market is likely to touch US$489.1 mn by the end of 2017. Further, the market is projected to witness a tremendous upswing at a CAGR of 15.20% during the period from 2017 to 2022 and attain a value of US$990.3 mn by the end of the forecast period. Standalone PV micro inverter systems are enjoying a stronger demand than their integrated counterparts. Researchers predict this setup will remain so over the period of forecast. Currently, the demand for PV micro inverters is higher in the residential sectors. Thanks to the rising demand for continuous supply of power from individuals, this trend is expected to continue in the near future.

Among all the regions, North America surfaced as the leading regional market for PV micro inverters, owing to the presence of a technologically advanced infrastructure. Rising at a healthy CAGR of 15% between 2017 and 2022, this regional market is predicted to maintain its dominance over the next few years. Asia Pacific, however, is likely to present the most lucrative opportunities for the market’s growth in the years to come. The presence of ample untapped potential and abundant solar power resource will support the Asia Pacific market for PV micro inverters to grow at a steady rate over the forthcoming years, reports the research study.

Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=30797

Need for Off Grid Electricity to Boost Demand for PV Micro Inverters

According to a TMR analyst, “PV micro inverters are expected to witness strong rise in their demand, thanks to the increasing need for off grid electricity across the world.” The rising concerns over safety and security from electricity has fueled the need for access to state-of-art resources of energy.

Apart from this, various favorable initiative by the governments in several countries, with an aim to encourage the usage of sustainable energy, such as net metering and feed in tariff, are also expected to promote the deployment of these inverters, complementing the growth of this market in the near future.

While the future of this market looks great, several challenges, such as the high cost incurred in the installation of these inverters, may limit their adoption over the next few years, reflecting negatively on this market, states the research report.

Buy PV Micro Inverters Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=30797&ltype=S

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/